diagnosis
This essential primer for patients and families on aplastic anemia covers causes, symptoms, classifications, treatments, and much more. With easy-to-read text and charts, and section review content, newly diagnosed…
Your Guide to Understanding AML (Acute Myeloid Leukemia)
This patient guide on AML begins with blood basics, AML diagnosis, and then specifics on symptoms, tests, actively managing your AML-related healthcare, and treatment options. *Disclaimer: New treatments may have been…
Athletic Canadian Continues Studies while in Treatment for Severe Aplastic Anemia: Geordy's Story
Geordy’s youth was an active one. Baseball, Soccer, and Hockey filled his days, even competing in the Little League World Series!
He was active in his family’s church, too. When offered the opportunity to go on a Youth with a Mission (YWAM) program to Australia, he traveled from his home in British Columbia to participate. Once there, the spark of ministry became a calling, so he attended college in Saskatchewan to become a pastor.
2025 EHA Update: Aplastic Anemia and PNH
Topic(s)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Aplastic Anemia
Presenter(s)
Phil Scheinberg, MD
In this webinar, Dr. Phillip Scheinberg will discuss the latest research presented at EHA about aplastic anemia and PNH. This is an advanced presentation. There will be a Q & A session and questions can be submitted in advance to help@aamds.org.
2025 EHA/ASCO Update: MDS and AML
Topic(s)
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
In this webinar, Dr. Jan Bewersdorf discusses the latest research presented at EHA and ASCO on MDS and AML. This is an advanced presentation.
MDS - MPN Overlap from the 2025 Chapel Hill Patient and Family Conference
Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Lacey Williams, MD
In this recording, Dr. Lacey Williams discusses the diagnosis of MDS/MPN overlap and the treatment options available to patients.
A Patient Story: Shauna McMillian - from the 2025 Chapel Hill Patient and Family Conference
Topic(s)
Myelodysplastic Syndromes (MDS)
Shauna describes her journey with MDS, or Myelodsplastic Syndromes, in this recorded session from the 2025 Chapel Hill Patient and Family Conference.
Aplastic Anemia from the 2025 Chapel Hill Patient and Family Conference
Topic(s)
COVID-19
Presenter(s)
Brandi Reeves, MD
In this recording, Dr. Brandi Reeves discusses the diagnosis of aplastic anemia and the treatment options available to patients.
A 30-gene classifier distinguishes low-risk MDS HSPCs from healthy HSPCs
Original Publication Date
Article Source
External Web Content
Highlights • Single-cell RNA-sequencing performed on 16 lower-risk myelodysplastic syndrome (LR-MDS) bone marrow-derived mononuclear cells (BMMCs) • A 30-gene signature distinguishes LR-MDS hematopoietic stem and progenitor cells (HSPCs) from Healthy HSPCs • Vesicular trafficking…
Sensitivity of Pediatric Myelodysplastic Syndromes With Excess of Blasts With UBTF–TD to Venetoclax/Azacitidine
Original Publication Date
Article Source
External Web Content
UBTF-TD has been reported in a significant percentage of childhood MDS-EB and has been associated with inferior survival compared to that of patients with the wild-type gene. We treated three consecutive pediatric patients affected by UBTF-TD MDS-EB with venetoclax and…
